Literature DB >> 18576565

Controlled expression and purification of human immune interferon from high-cell-density fermentations of Saccharomyces cerevisiae.

J C Fieschko1, K M Egan, T Ritch, R A Koski, M Jones, G A Bitter.   

Abstract

Conditions for high-cell-density fermentations of Saccharomyces cerevisiae strains producing recombinant-DNA-derived proteins were established. Strains producing human immune interferon (IFN-gamma) from the constitutive PGK promoter failed to grow to high cell densities and exhibited low plasmid stability. Regulated expression of IFN-gamma was obtained in similar strains by employing a hybrid yeast GPD promoter that was subject to carbon source regulation due to the presence of regulatory DNA sequences from the yeast GAL 1,10 intergenic region. IFN-gamma expression programmed by this vector was low during growth on glucose and was induced by galactose. Previously defined fermentation conditions employing glucose as a carbon source were applied to this strain, resulting in high ceil densities with higher plasmid stability. Various methods of galactose induction of IFN-gamma expression in high-cell-density fermentations were investigated. Optimal conditions resulted in a 2000-fold induction and production of 2 g IFN-gamma/L fermentation culture.

Entities:  

Year:  1987        PMID: 18576565     DOI: 10.1002/bit.260290911

Source DB:  PubMed          Journal:  Biotechnol Bioeng        ISSN: 0006-3592            Impact factor:   4.530


  7 in total

1.  The prepro-peptide of Mucor rennin directs the secretion of human growth hormone by Saccharomyces cerevisiae.

Authors:  R Hiramatsu; T Yamashita; J Aikawa; S Horinouchi; T Beppu
Journal:  Appl Environ Microbiol       Date:  1990-07       Impact factor: 4.792

2.  Yeast-derived recombinant human insulin-like growth factor I: production, purification, and structural characterization.

Authors:  S Elliott; K D Fagin; L O Narhi; J A Miller; M Jones; R Koski; M Peters; P Hsieh; R Sachdev; R D Rosenfeld
Journal:  J Protein Chem       Date:  1990-02

3.  Characterization of two fluorescent tryptophans in recombinant human granulocyte-colony stimulating factor: comparison of native sequence protein and tryptophan-deficient mutants.

Authors:  C G Kolvenbach; S Elliott; R Sachdev; T Arakawa; L O Narhi
Journal:  J Protein Chem       Date:  1993-04

Review 4.  Physiological aspects of growth and recombinant DNA stability in Saccharomyces cerevisiae.

Authors:  C A Mason
Journal:  Antonie Van Leeuwenhoek       Date:  1991-05       Impact factor: 2.271

5.  Optimization of the expression system using galactose-inducible promoter for the production of anticoagulant hirudin in Saccharomyces cerevisiae.

Authors:  E S Choi; J H Sohn; S K Rhee
Journal:  Appl Microbiol Biotechnol       Date:  1994-12       Impact factor: 4.813

6.  Growth rate control in fed-batch cultures of recombinant Saccharomyces cerevisiae producing hepatitis B surface antigen (HBsAg).

Authors:  M B Gu; M H Park; D I Kim
Journal:  Appl Microbiol Biotechnol       Date:  1991-04       Impact factor: 4.813

Review 7.  Physiological and technological aspects of large-scale heterologous-protein production with yeasts.

Authors:  M C Hensing; R J Rouwenhorst; J J Heijnen; J P van Dijken; J T Pronk
Journal:  Antonie Van Leeuwenhoek       Date:  1995       Impact factor: 2.271

  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.